Designation of the project | Leukospin, Leukocyte marker infection diagnostic solution Project Code | COMPETE2030-FEDER-01174400 Beneficiary | biosurfit S.A.
Start date | 01-05-2024 End Date | 30-04-2026 Total eligible value | 1 141 061,10€ EU Financing | 889 734,66€ EU co-financing | 77,97%
Project Summary
Leukospin is an innovative sepsis diagnostic solution that differentiates between bacterial and viral infections. The project combines microfluidics, next-generation fluorescence microscopy and machine learning, which will allow analysis of up to 24 fluorescent markers in a single blood sample. This solution promises fast, accurate and affordable diagnostics, changing the paradigm in the treatment of septicemia and serious infections.
Learn more about the project on this video:
Failed to load the Page FontsWe apologize, but the user experience may not be the best!Got it